Citations for
1PRSS3, TFPI2
PO-44 - Tissue factor pathway inhibitor-2 (TFPI-2) is cleaved by PRSS3: implication for tumor endothelial cells migration.
Ghilardi C, Anastasia A, Avigni R, Lupi M, Giavazzi R, Bani MR.
Thromb Res 140 Suppl 1:S192-3. doi: 10.1016/S0049-3848(16)30177-3. Epub 2016 Apr 8. 2016
2PRSS3, TFPI2
Trypsinogen 4 boosts tumor endothelial cells migration through proteolysis of tissue factor pathway inhibitor-2.
Ghilardi C, Silini A, Figini S, Anastasia A, Lupi M, Fruscio R, Giavazzi R, Bani MR.
Oncotarget 6(29):28389-400. doi: 10.18632/oncotarget.4949. 2015
3PRSS3, TFPI2
Mesotrypsin and caspase-14 participate in prosaposin processing: potential relevance to epidermal permeability barrier formation.
Yamamoto-Tanaka M, Motoyama A, Miyai M, Matsunaga Y, Matsuda J, Tsuboi R, Hibino T.
J Biol Chem 289(29):20026-38. doi: 10.1074/jbc.M113.543421. Epub 2014 May 28. 2014
4TFPI2
Knockdown of TFPI-2 promotes migration and invasion of glioma cells.
Gessler F, Voss V, Seifert V, Gerlach R, Kögel D.
Neurosci Lett 497(1):49-54. Epub 2011 Apr 20. 2011
5TFPI2
Tissue factor pathway inhibitor 2 is induced by thrombin in human macrophages.
Pou J, Rebollo A, Piera L, Merlos M, Roglans N, Laguna JC, Alegret M.
Biochim Biophys Acta 1813(6):1254-60. Epub 2011 Apr 15. 2011
6TFPI2
Methylation of the CpG sites only on the sense strand of the APC gene is specific for hepatocellular carcinoma.
Jain S, Chang TT, Hamilton JP, Lin SY, Lin YJ, Evans AA, Selaru FM, Lin PW, Chen SH, Block TM, Hu CT, Song W, Meltzer SJ, Su YH.
PLoS One 6(11):e26799. Epub 2011 Nov 2. 2011
7TFPI2
TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma.
Wang S, Xiao X, Zhou X, Huang T, Du C, Yu N, Mo Y, Lin L, Zhang J, Ma N, Murata M, Huang G, Zhang Z.
BMC Cancer 10:617. 2010
8CLDN6, FBN2, RBP4, TFPI2, TMEFF2
Methylation of CLDN6, FBN2, RBP1, RBP4, TFPI2, and TMEFF2 in esophageal squamous cell carcinoma.
Tsunoda S, Smith E, De Young NJ, Wang X, Tian ZQ, Liu JF, Jamieson GG, Drew PA.
Oncol Rep 21(4):1067-73. 2009
9TFPI2
A novel role for tissue factor pathway inhibitor-2 in the therapy of human esophageal carcinoma.
Ran Y, Pan J, Hu H, Zhou Z, Sun L, Peng L, Yu L, Sun L, Liu J, Yang Z.
Hum Gene Ther 20(1):41-9. 2009
10TFPI2
Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer.
Glöckner SC, Dhir M, Yi JM, McGarvey KE, Van Neste L, Louwagie J, Chan TA, Kleeberger W, de Bruďne AP, Smits KM, Khalid-de Bakker CA, Jonkers DM, Stockbrügger RW, Meijer GA, Oort FA, Iacobuzio-Donahue C, Bierau K, Herman JG, Baylin SB, Van Engeland M, Schuebel KE, Ahuja N.
Cancer Res 69(11):4691-9. Epub 2009 May 12. 2009
11TFPI2
Human tissue factor pathway inhibitor-2 is internalized by cells and translocated to the nucleus by the importin system.
Kempaiah P, Chand HS, Kisiel W.
Arch Biochem Biophys 482(1-2):58-65. Epub 2008 Dec 10. 2009
12TFPI2
Human tissue factor pathway inhibitor-2 induces caspase-mediated apoptosis in a human fibrosarcoma cell line.
Kempaiah P, Kisiel W.
Apoptosis 13(5):702-15. 2008
13TFPI2
Identification of a human TFPI-2 splice variant that is upregulated in human tumor tissues.
Kempaiah P, Chand HS, Kisiel W.
Mol Cancer 6:20. 2007
14TFPI2
Adenovirus-mediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis.
Ivanciu L, Gerard RD, Tang H, Lupu F, Lupu C.
Arterioscler Thromb Vasc Biol 27(2):310-6. Epub 2006 Nov 30. 2007
15ADAMTS1, TFPI2
ADAMTS1 interacts with, cleaves, and modifies the extracellular location of the matrix inhibitor tissue factor pathway inhibitor-2.
Torres-Collado AX, Kisiel W, Iruela-Arispe ML, Rodriguez-Manzaneque JC.
J Biol Chem 281(26):17827-37. Epub 2006 Apr 26. 2006
16TFPI2
Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells.
Xu Z, Maiti D, Kisiel W, Duh EJ.
Arterioscler Thromb Vasc Biol 26(12):2819-25. Epub 2006 Oct 5. 2006
17TFPI2
Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma.
Jiang P, Watanabe H, Okada G, Ohtsubo K, Mouri H, Tsuchiyama T, Yao F, Sawabu N.
Cancer Sci 97(11):1267-73. Epub 2006 Sep 5. 2006
18TFPI2
Characterization and functional analysis of TFPI-2 gene promoter in a human choriocarcinoma cell line.
Hube F, Reverdiau P, Iochmann S, Cherpi-Antar C, Gruel Y.
Thromb Res 109(4):207-15. 2003
19TFPI2
Transcriptional silencing of the TFPI-2 gene by promoter hypermethylation in choriocarcinoma cells.
Hube F, Reverdiau P, Iochmann S, Rollin J, Cherpi-Antar C, Gruel Y.
Biol Chem 384(7):1029-34. 2003
20TFPI2
Genomic structure and promoter activity of the human tissue factor pathway inhibitor-2 gene.
Kamei S, Kazama Y, Kuijper JL, Foster DC, Kisiel W.
Biochim Biophys Acta 1517(3):430-5. 2001
21TFPI2
Assignment of the human PP5/TFPI-2 gene to 7q22 by FISH and PCR-based human/rodent cell hybrid mapping panel analysis.
Miyagi Y, et al.
Genomics 35 : 267-268. 1996
22TFPI2
Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
Petersen LC, et al.
Biochemistry 35(1):266-72 1996
23TFPI2
Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor.
Sprecher CA, et al.
Proc Natl Acad Sci U S A 91 : 3353-3357. 1994
24TFPI2
cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells : identification as placental protein 5 and tissue factor pathway inhibitor-2.
Miyagi Y, et al.
J Biochem 116 : 939-942. 1994